'en:clag protocol'
(id=7141882 ; fe=en:clag protocol ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=107 creation date=2017-06-25 touchdate=2025-04-26 19:08:21.000) ≈ 5 relations sortantes
- en:clag protocol --
r_associated #0: 32 / 1 ->
en:cytarabine
n1=en:clag protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
- en:clag protocol --
r_associated #0: 30 / 0.938 ->
en:granulocyte colony-stimulating factor
n1=en:clag protocol | n2=en:granulocyte colony-stimulating factor | rel=r_associated | relid=0 | w=30
- en:clag protocol --
r_associated #0: 29 / 0.906 ->
en:cladribine
n1=en:clag protocol | n2=en:cladribine | rel=r_associated | relid=0 | w=29
- en:clag protocol --
r_associated #0: 26 / 0.813 ->
en:antineoplastic combined chemotherapy protocols
n1=en:clag protocol | n2=en:antineoplastic combined chemotherapy protocols | rel=r_associated | relid=0 | w=26
- en:clag protocol --
r_associated #0: 2 / 0.063 ->
en:therapeutic or preventive procedure
n1=en:clag protocol | n2=en:therapeutic or preventive procedure | rel=r_associated | relid=0 | w=2
| ≈ 6 relations entrantes
- en:granulocyte colony-stimulating factor ---
r_associated #0: 30 -->
en:clag protocol
n1=en:granulocyte colony-stimulating factor | n2=en:clag protocol | rel=r_associated | relid=0 | w=30
- en:antineoplastic combined chemotherapy protocols ---
r_associated #0: 20 -->
en:clag protocol
n1=en:antineoplastic combined chemotherapy protocols | n2=en:clag protocol | rel=r_associated | relid=0 | w=20
- en:cladribine ---
r_associated #0: 20 -->
en:clag protocol
n1=en:cladribine | n2=en:clag protocol | rel=r_associated | relid=0 | w=20
- en:cytarabine ---
r_associated #0: 20 -->
en:clag protocol
n1=en:cytarabine | n2=en:clag protocol | rel=r_associated | relid=0 | w=20
- cytarabine ---
r_associated #0: 10 -->
en:clag protocol
n1=cytarabine | n2=en:clag protocol | rel=r_associated | relid=0 | w=10
- cladribine ---
r_associated #0: 5 -->
en:clag protocol
n1=cladribine | n2=en:clag protocol | rel=r_associated | relid=0 | w=5
|